Literature DB >> 29135021

Diagnostic Accuracy of the Chinese Version of the Trail-Making Test for Screening Cognitive Impairment.

Mingqing Wei1, Jing Shi1, Ting Li1, Jingnian Ni1, Xuekai Zhang1, Yumeng Li1, Shenghua Kang1, Fuyun Ma1, Hengge Xie2, Bin Qin3, Dongsheng Fan4, Liping Zhang5, Yongyan Wang6, Jinzhou Tian1.   

Abstract

BACKGROUND/
OBJECTIVES: The Trail-Making Test (TMT), which is commonly used to measure executive function, consists of two components (TMT-A and TMTB). There is a lack of normative TMT data for Chinese elderly adults. This study aimed to evaluate the validity of the TMT in screening for cognitive impairment.
DESIGN: 2,294 Chinese-speaking adults aged 50 to 85: 1,026 with normal cognition (NC), 462 with mild cognitive impairment (MCI), 108 with Alzheimer's disease (AD), 113 with vascular mild cognitive impairment (VaMCI), 121 with vascular dementia (VaD), 282 with uncertain types of dementia, and 15 with mixed dementia. Receiver operating characteristic curve analysis was performed to test the ability of TMT scores to differentiate between NC and cognitive impairment.
RESULTS: Age, education, and sex were significantly associated with TMT completion time. The TMT-A exhibited sensitivity of 77.8% and specificity of 92.0% with cut-off value of 98.5 seconds for discriminating AD from NC. The TMT-B had sensitivity of 83.3% and specificity of 91.8% with a cut-off value of 188.5 seconds for discriminating AD from NC. The TMT-A had sensitivity of 85.7% and specificity of 81.6% for discriminating NC from VaD with a cut-off value of 77.5 seconds, and the TMT-s had sensitivity of 81.6% and specificity of 83.9% with a cut-off value of 147.5 seconds. The TMT had less sensitivity distinguishing MCI from NC.
CONCLUSION: The Chinese version of the TMT is reliable for detecting AD or VaD but poor at distinguishing MCI from NC.
© 2017, The Authors. The Journal of the American Geriatrics Society published by Wiley Periodicals, Inc. on behalf of The American Geriatrics Society.

Entities:  

Keywords:  Alzheimer's disease; Trail-Making Test; clinical norms; vascular dementia

Mesh:

Year:  2017        PMID: 29135021     DOI: 10.1111/jgs.15135

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  22 in total

1.  American Geriatrics Society and National Institute on Aging Bench-to-Bedside Conference: Sensory Impairment and Cognitive Decline in Older Adults.

Authors:  Heather E Whitson; Alice Cronin-Golomb; Karen J Cruickshanks; Grover C Gilmore; Cynthia Owsley; Jonathan E Peelle; Gregg Recanzone; Anu Sharma; Bonnielin Swenor; Kristine Yaffe; Frank R Lin
Journal:  J Am Geriatr Soc       Date:  2018-09-24       Impact factor: 5.562

2.  Methylation of the RIN3 Promoter is Associated with Transient Ischemic Stroke/Mild Ischemic Stroke with Early Cognitive Impairment.

Authors:  Meng Miao; Fang Yuan; Xiaotian Ma; Haiming Yang; Xiang Gao; Zhengyu Zhu; Jianzhong Bi
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-10       Impact factor: 2.570

3.  Chinese version of the auditory verbal learning test: normative study and clinical applications in Chinese-speaking population in Shijiazhuang city.

Authors:  Fang-Ming Dong; Wei Wang; Shang-Zun Guo; Kai Shao; Ya-Xue Song; Ning Han; Yan-Li Jia; Rong-Fang Feng; Jian-Hua Wang
Journal:  Acta Neurol Belg       Date:  2022-07-30       Impact factor: 2.471

4.  Patterns of cognitive function in middle-aged and elderly Chinese adults-findings from the EMCOA study.

Authors:  Yu An; Lingli Feng; Xiaona Zhang; Ying Wang; Yushan Wang; Lingwei Tao; Yanhui Lu; Zhongsheng Qin; Rong Xiao
Journal:  Alzheimers Res Ther       Date:  2018-09-15       Impact factor: 6.982

5.  A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.

Authors:  Mingqing Wei; Jing Shi; Jingnian Ni; Xuekai Zhang; Ting Li; Zilong Chen; Mengling Zhou; Liping Zhang; Zhongjian Tan; Yongyan Wang; Jinzhou Tian
Journal:  BMC Geriatr       Date:  2019-02-28       Impact factor: 3.921

6.  Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial.

Authors:  Jing Shi; Mingqing Wei; Jingnian Ni; Feng Sun; Li Sun; Junfu Wang; Tao Yu; Kai Wang; Peiyuan Lv; Yunfu Wang; Yulian Zhang; Xuguang Gao; Xuanzhao Gao; Benyan Luo; Shanping Mao; Baorong Zhang; Xiangyang Ren; Fengchun Yu; Wenli Hu; Ping Yin; Nanjin Wu; Xianfeng Liu; Qi Bi; Yongyan Wang; Jinzhou Tian
Journal:  J Transl Med       Date:  2020-02-13       Impact factor: 5.531

7.  Microstructural damage of normal-appearing white matter in subcortical ischemic vascular dementia is associated with Montreal Cognitive Assessment scores.

Authors:  Zhangyuan Liao; Chun Dang; Meijie Li; Yali Bu; Ranran Han; Wei Jiang
Journal:  J Int Med Res       Date:  2019-07-25       Impact factor: 1.671

8.  Effect of Baduanjin exercise intervention on cognitive function and quality of life in women with breast cancer receiving chemotherapy: study protocol of a randomized controlled trial.

Authors:  Xiao-Lin Wei; Ru-Zhen Yuan; Yong-Mei Jin; Shu Li; Ming-Yue Wang; Jie-Ting Jiang; Cai-Qin Wu; Kun-Peng Li
Journal:  Trials       Date:  2021-06-19       Impact factor: 2.279

9.  Microstructural damage pattern of vascular cognitive impairment: a comparison between moyamoya disease and cerebrovascular atherosclerotic disease.

Authors:  Jia-Bin Su; Si-Da Xi; Shu-Yi Zhou; Xin Zhang; Shen-Hong Jiang; Bin Xu; Liang Chen; Yu Lei; Chao Gao; Yu-Xiang Gu
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

10.  Dysfunction of Inferior Parietal Lobule During Sensory Gating in Patients With Amnestic Mild Cognitive Impairment.

Authors:  Chia-Hsiung Cheng; Fu-Jung Hsiao; Yu-Wei Hsieh; Pei-Ning Wang
Journal:  Front Aging Neurosci       Date:  2020-02-25       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.